CapsoVision, Inc (NASDAQ: CV)

Sector: Healthcare Industry: Medical Devices CIK: 0001378325
Market Cap 32.80 Mn
P/B 1.60
P/E -1.65
P/S 2.79
ROIC (Qtr) 0.00
Div Yield % 0.00
Rev 1y % (Qtr) 19.29
Total Debt (Qtr) 978,000.00
Debt/Equity (Qtr) 0.05
Add ratio to table...

About

Investment thesis

Bull case

  • Healthy cash reserves of 17.79M provide 45.14x coverage of short-term debt 394000, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 25.66M provides 26.24x coverage of total debt 978000, indicating robust asset backing and low credit risk.
  • Tangible assets of 25.66M provide exceptional 242.08x coverage of deferred revenue 106000, showing strong service capability backing.
  • Tangible assets of 25.66M provide robust 8.86x coverage of other current liabilities 2.90M, indicating strong asset backing.
  • Strong cash position of 17.79M provides 6.14x coverage of other current liabilities 2.90M, indicating excellent liquidity.

Bear case

  • Operating cash flow of 0 provides insufficient coverage of deferred revenue obligations of 106000, which is 0x, raising concerns about future service delivery capabilities.
  • Tangible assets of 25.66M provide limited backing for working capital of 19.41M, which is 1.32x, suggesting increased operational risk in market downturns.
  • Other non-current assets of 41000 provide minimal coverage for long-term debt of 584000, which is 0.07x, indicating potential asset-liability mismatch.
  • Other current liabilities of 2.90M represent a high 1.55x of receivables 1.87M, suggesting potential short-term liquidity pressure.

Peer comparison

Companies in the Medical Devices
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 ABT Abbott Laboratories 173.80 Bn 32.73 5.47 12.94 Bn
2 SYK Stryker Corp 141.15 Bn 43.48 5.62 15.86 Bn
3 MDT Medtronic plc 123.47 Bn 25.92 3.55 29.10 Bn
4 BSX Boston Scientific Corp 112.80 Bn 38.92 5.62 11.44 Bn
5 EW Edwards Lifesciences Corp 45.66 Bn 33.38 7.76 0.70 Bn
6 DXCM Dexcom Inc 27.52 Bn 32.91 5.90 1.34 Bn
7 STE STERIS plc 24.13 Bn 34.08 4.14 2.05 Bn
8 PODD Insulet Corp 17.33 Bn 70.38 6.87 1.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.00 2.13
EV to Cash from Ops. EV to Cash from Ops. 0.00 2.75
EV to Debt EV to Debt 0.00 17.25
EV to EBIT EV to EBIT 0.00 2.89
EV to EBITDA EV to EBITDA 0.00 4.53
EV to Free Cash Flow [EV/FCF] EV to Free Cash Flow [EV/FCF] 0.00 29.36
EV to Market Cap EV to Market Cap 0.00 25.09
EV to Revenue EV to Revenue 0.00 32.80
Price to Book Value [P/B] P/B 1.60 4.73
Price to Earnings [P/E] P/E -1.65 -2.04
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 40.22
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 1.59
Dividend per Basic Share Div per Share (Qtr) 0.00 0.10
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 -0.37
Interest Coverage Interest Coverage 0.00 196.93
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 0.00 -152.08
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 0.00 8,476.58
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -0.44
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 0.00 -792.16
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 0.00 3.79
EBIT Growth (1y) % EBIT 1y % (Qtr) 0.00 -301.80
EBT Growth (1y) % EBT 1y % (Qtr) 0.00 -121.44
EPS Growth (1y) % EPS 1y % (Qtr) 0.00 -87.51
FCF Growth (1y) % FCF 1y % (Qtr) 0.00 10.43
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 0.00 38.21
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 0.55
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.02
Cash Ratio Cash Ratio (Qtr) 3.84 1.80
Current Ratio Curr Ratio (Qtr) 5.19 4.18
Debt to Equity Ratio Debt/Equity (Qtr) 0.05 1.20
Interest Cover Ratio Interest Cover Ratio 0.00 196.93
Times Interest Earned Times Interest Earned 0.00 196.93
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 0.00 -2,396.63
EBIT Margin % EBIT Margin % (Qtr) 0.00 -2,478.60
EBT Margin % EBT Margin % (Qtr) 0.00 -2,690.42
Gross Margin % Gross Margin % (Qtr) 0.00 30.80
Net Profit Margin % Net Margin % (Qtr) 0.00 -2,821.53